tykhr
sign in
free sign up
Aridis Pharmaceuticals Inc
Biotechnology
Healthcare
ARDS
14.50 M shares
NASDAQ US
traded
11 Jan 2023
listed
yes
open
1.36
52 week high
7.49
high
1.36
52 week low
1.32
low
1.30
growth
-15.63 %
previous Close
1.33
P/E ratio
market cap
32.39 M
div yield
0
usd
Jun 2022
qoq
revenue
292 K
-48.77 %
net incoming
-7.98 M
21.98 %
eps
0.00 %
51.09 %
eps surprise
-650.00 %
net profit margin
-2732.53 %
-938.00 %
operating incoming
-7.74 M
22.39 %
net change in cash
-6.29 M
66.40 %
cash on hand
6.32 M
-68.39 %
cost of revenue
0.00 %
top